Faruque Ghanchi

Hon. Visiting Professor

University of Bradford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Faruque Ghanchi is an Hon. Visiting Professor at the University of Bradford in the UK. His research primarily focuses on ophthalmology, with significant contributions to the understanding and management of age-related macular degeneration and diabetic macular edema. Recent articles authored by him explore topics such as visual outcomes related to anti-vascular endothelial growth factor treatments and the implications for clinical trial designs.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Pádraig J. Mulholland

UNITED KINGDOM

View details

Corinne Fulcher

University of Huddersfield

UNITED KINGDOM

View details

Richard P. Gale

Professor of Ophthalmology

University of York

UNITED KINGDOM

View details

Rhianon Reynolds

Senior lecturer

Cardiff University

UNITED KINGDOM

View details

Winfried Amoaku

University of Nottingham

UNITED KINGDOM

View details

Sobha Sivaprasad

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Faruque Ghanchi

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion

Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6

Factors associated with achieving various visual acuity outcomes during loading doses of aflibercept 2 mg for treatment naïve exudative age-related macular degeneration: PRECISE Study Report 7

Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3

Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2

Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes

Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients

Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes

Inclusive research in ophthalmology is mission critical! The 10-point action plan

The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice

An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma

Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes

Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration

Optical coherence tomography angiography for identifying choroidal neovascular membranes: a masked study in clinical practice

<p>Trends in Real-World Neovascular AMD Treatment Outcomes in the UK</p>

Collaborators (6)

Pádraig J. Mulholland

Corinne Fulcher

Richard P. Gale

Rhianon Reynolds

Winfried Amoaku

Sobha Sivaprasad

Make your next move.